David is a General Partner of Cultivation Capital Life Sciences Fund, a venture fund focused on life science investing with companies in the therapeutics, diagnostic instruments, healthcare IT, research tools and agriculture sectors. He has served in various leadership roles with Sigma-Aldrich, ProteoPlex, a company he founded in 2001, and EMD Biosciences. Prior to those roles he founded and served as Chief Executive Officer of Genome Systems, and then assumed a leadership position at Incyte Corporation. David earned a Doctorate degree in Molecular Biology and a Bachelor’s degree in Biology from Emory University in Atlanta.